NO961460L - Antitrombotiske azacykloalkylalkanoylpeptider og -pseudopeptider - Google Patents

Antitrombotiske azacykloalkylalkanoylpeptider og -pseudopeptider

Info

Publication number
NO961460L
NO961460L NO961460A NO961460A NO961460L NO 961460 L NO961460 L NO 961460L NO 961460 A NO961460 A NO 961460A NO 961460 A NO961460 A NO 961460A NO 961460 L NO961460 L NO 961460L
Authority
NO
Norway
Prior art keywords
aralkyl
substituted
aryl
alkyl
alkylcycloalkyl
Prior art date
Application number
NO961460A
Other languages
English (en)
Norwegian (no)
Other versions
NO961460D0 (no
Inventor
Scott I Klein
Bruce F Molino
Original Assignee
Rhone Poulenc Rorer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Inc filed Critical Rhone Poulenc Rorer Inc
Publication of NO961460D0 publication Critical patent/NO961460D0/no
Publication of NO961460L publication Critical patent/NO961460L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • C07K5/06113—Asp- or Asn-amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO961460A 1993-10-15 1996-04-12 Antitrombotiske azacykloalkylalkanoylpeptider og -pseudopeptider NO961460L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13882093A 1993-10-15 1993-10-15
PCT/US1994/012135 WO1995010295A1 (en) 1993-10-15 1994-10-17 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides

Publications (2)

Publication Number Publication Date
NO961460D0 NO961460D0 (no) 1996-04-12
NO961460L true NO961460L (no) 1996-06-17

Family

ID=22483811

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961460A NO961460L (no) 1993-10-15 1996-04-12 Antitrombotiske azacykloalkylalkanoylpeptider og -pseudopeptider

Country Status (27)

Country Link
US (1) US5866685A (pl)
EP (1) EP0812205B1 (pl)
JP (1) JP3032297B2 (pl)
KR (1) KR100304332B1 (pl)
CN (1) CN1135717A (pl)
AT (1) ATE199727T1 (pl)
AU (1) AU703854B2 (pl)
BG (1) BG63166B1 (pl)
BR (1) BR9407839A (pl)
CA (1) CA2174097C (pl)
CZ (1) CZ291378B6 (pl)
DE (1) DE69426897T2 (pl)
DK (1) DK0812205T3 (pl)
ES (1) ES2155122T3 (pl)
FI (1) FI961634L (pl)
GR (1) GR3035581T3 (pl)
HU (1) HU222248B1 (pl)
NO (1) NO961460L (pl)
NZ (1) NZ275948A (pl)
PL (1) PL181749B1 (pl)
PT (1) PT812205E (pl)
RO (1) RO115520B1 (pl)
RU (1) RU2134695C1 (pl)
SG (1) SG64919A1 (pl)
SK (1) SK47796A3 (pl)
UA (1) UA44258C2 (pl)
WO (1) WO1995010295A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780590A (en) * 1993-10-15 1998-07-14 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
US6274705B1 (en) * 1996-05-02 2001-08-14 Aventis Pharmaceuticals Products Inc. Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
US5866685A (en) * 1993-10-15 1999-02-02 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
AP9901462A0 (en) * 1996-08-21 1999-03-31 Aventis Pharmaceuticals Products Inc Stable non-hygroscopic crystalline form of N-[N-N-(4-(Piperidin-4-YL)Butanoyl)-N-Ethylglycyl] amide.
SI0946185T2 (sl) * 1996-11-27 2010-08-31 Aventis Pharma Inc Farmacevtski sestavek, ki obsega spojino z anti-Xa-aktivnostjo in antagonistično spojino za agregacijo ploščic
WO1999019294A1 (en) * 1997-05-14 1999-04-22 Aventis Pharmaceuticals Products Inc. Legal/Patents Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides
CN1278791A (zh) * 1997-10-10 2001-01-03 阿温蒂斯药物制品公司 制造氮杂环烷基烷酰基假四肽的方法
AU2844800A (en) * 1998-12-30 2000-07-24 Aventis Pharmaceuticals Products Inc. Process for preparing a stable non-hygroscopic crystalline n-(n-(n- piperdin- 4-yl)butanoyl)- n.ethylglycyl)- (l)-aspartyl) -ss-cyclohexylalanine amide
HUP0301986A2 (hu) * 2000-01-28 2003-09-29 Aventis Pharma Deutschland Gmbh. Eljárás acetil-amidinofenilalanil-ciklohexilglicil-piridinioalanin-amidok elżállítására, valamint kiindulási anyagok és köztitermékek
CN1229339C (zh) * 2000-03-27 2005-11-30 斯克里普斯研究学院 抑制血管生成和肿瘤生长的化合物，含有该化合物的药用制剂，以及该化合物的制药用途
CN101735307B (zh) * 2008-11-18 2012-05-30 北京航空航天大学 一种血小板膜糖蛋白寡肽或其修饰物/衍生物以及它们的应用
MX2014015197A (es) * 2012-06-11 2015-11-16 Cleveland Clinic Foundation Tratamiento y prevencion de la enfermedad cardiovascular y trombosis.

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683291A (en) * 1985-10-28 1987-07-28 Scripps Clinic And Research Foundation Platelet binding inhibitors
FR2608160B1 (fr) * 1986-12-15 1989-03-31 Inst Nat Sante Rech Med Nouveaux derives peptidiques et leur application notamment en therapeutique
US4857508A (en) * 1987-12-03 1989-08-15 Monsanto Company Novel platelet-aggregation inhibitor peptide derivatives
US5037808A (en) * 1988-07-20 1991-08-06 Monsanto Co. Indolyl platelet-aggregation inhibitors
US4992463A (en) * 1988-07-20 1991-02-12 Monsanto Company Thienyl peptide mimetic compounds which are useful in inhibiting platelet aggregation
US4879313A (en) * 1988-07-20 1989-11-07 Mosanto Company Novel platelet-aggregation inhibitors
CA2008116C (en) * 1989-02-23 2001-11-20 Thomas Weller Glycine derivatives
US5023233A (en) * 1989-07-28 1991-06-11 Merck & Co., Inc. Fibrinogen receptor antagonists
EP0494248A4 (en) * 1989-09-29 1992-08-26 Rhone-Poulenc Rorer International (Holdings) Inc. Anti-thrombotic peptides and pseudopeptides
US5051405A (en) * 1989-10-10 1991-09-24 Rhone-Poulenc Rorer Pharmaceuticals Inc. Anti-thrombotic peptides and pseudopeptides
US5064814A (en) * 1990-04-05 1991-11-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Anti-thrombotic peptide and pseudopeptide derivatives
IL99539A0 (en) * 1990-09-27 1992-08-18 Merck & Co Inc Fibrinogen receptor antagonists and pharmaceutical compositions containing them
NZ239876A (en) * 1990-09-27 1993-12-23 Merck & Co Inc Glycyl-b-alanine derivatives and pharmaceutical compositions thereof.
EP0503203A1 (en) * 1991-03-15 1992-09-16 Merrell Dow Pharmaceuticals Inc. Novel thrombin inhibitors
WO1992018117A1 (en) * 1991-04-11 1992-10-29 Rhone-Poulenc Rorer International (Holdings), Inc. Anti-thrombotic peptide and pseudopeptide derivatives
SE9102462D0 (sv) * 1991-08-28 1991-08-28 Astra Ab New isosteric peptides
US5866685A (en) * 1993-10-15 1999-02-02 Rhone-Poulenc Rorer Pharmaceuticals Inc. Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides

Also Published As

Publication number Publication date
CN1135717A (zh) 1996-11-13
CZ291378B6 (cs) 2003-02-12
WO1995010295A1 (en) 1995-04-20
EP0812205A4 (en) 1999-03-31
JPH09507213A (ja) 1997-07-22
DK0812205T3 (da) 2001-04-17
ATE199727T1 (de) 2001-03-15
CZ108496A3 (en) 1996-12-11
SG64919A1 (en) 1999-05-25
HU222248B1 (hu) 2003-05-28
ES2155122T3 (es) 2001-05-01
PL313975A1 (en) 1996-08-05
EP0812205B1 (en) 2001-03-14
JP3032297B2 (ja) 2000-04-10
HUT73856A (en) 1996-09-30
US5866685A (en) 1999-02-02
SK47796A3 (en) 1997-03-05
CA2174097A1 (en) 1995-04-20
DE69426897T2 (de) 2001-07-05
PT812205E (pt) 2001-08-30
DE69426897D1 (de) 2001-04-19
NO961460D0 (no) 1996-04-12
GR3035581T3 (en) 2001-06-29
RU2134695C1 (ru) 1999-08-20
HU9600983D0 (en) 1996-06-28
AU8123794A (en) 1995-05-04
CA2174097C (en) 2002-06-04
BR9407839A (pt) 1997-05-13
AU703854B2 (en) 1999-04-01
HK1006225A1 (en) 1999-02-19
FI961634A7 (fi) 1996-05-23
RO115520B1 (ro) 2000-03-30
UA44258C2 (uk) 2002-02-15
BG100544A (bg) 1996-11-29
BG63166B1 (bg) 2001-05-31
EP0812205A1 (en) 1997-12-17
FI961634A0 (fi) 1996-04-12
KR100304332B1 (ko) 2001-11-26
NZ275948A (en) 1997-02-24
FI961634L (fi) 1996-05-23
PL181749B1 (pl) 2001-09-28

Similar Documents

Publication Publication Date Title
RU2170232C2 (ru) Амиды фосфиновых кислот и способ предупреждения или лечения заболевания, связанного с нежелательной активностью металлопротеазы
DE60034447T2 (de) Nicht-kovalente Urokinase-und Angiogenese-Inhibitoren
ES2379948T3 (es) Composición medicinal que comprende Tacrine o Donepezil para mejorar la función cerebral
ES2040242T3 (es) Composiciones farmaceuticas.
KR20000035918A (ko) 1,3-디헤테로시클릭 메탈로프로테아제 저해제
PT89346B (pt) Processo para a preparacao de novas lactamas triciclicas contendo grupos sulfridilo e de composicoes farmaceuticas que as contem
MX9707531A (es) Nuevos compuestos heterociclicos.
MXPA04000338A (es) Diamindioles para tratamiento de enfermedad de alzheimer.
KR20010042694A (ko) 치환 피롤리딘 히드록사메이트 메탈로프로테아제 억제제
US5190937A (en) Lactam derivatives
MXPA03011521A (es) Aminadioles para tratamiento de enfermedad de alzheimer.
RU94036771A (ru) Ингибиторы ангиогенеза и ангиогенных заболеваний
DE69125216D1 (de) Aminoalkanesulfonsäurederivate und pharmazeutische Zusammensetzungen davon zur Prävention oder Behandlung von Herzerkrankungen
FI961634A0 (fi) Antitromboottisia atsasykloalkyylialkanoyyli peptidejä ja pseudopeptidejä
IL93989A0 (en) Pharmaceutical compositions comprising heteroaryl-3-oxo-propanenitrile derivatives useful in the treatment of rheumatoid arthritis and other autoimmune diseases
AU5100296A (en) Novel heterocyclic compounds
MXPA04000337A (es) Amindioles para tratamiento de enfermedad de alzheimer.
BG100246A (en) N-substituted azaheterocylic carboxylic acids and their esters
ZA891769B (en) Heterocyclic compounds
EP0612324A1 (en) Phosphonopeptides with collagenase inhibiting activity
BR0214293A (pt) Composto e métodos para tratar um paciente que tenha, ou de prevenir um paciente de adquirir, uma doença ou condição e para produzir um composto ou um sal ou éster farmaceuticamente aceitável do mesmo
US5932551A (en) Substituted N-carboxyalkylpeptidyl derivatives as antidegenerative active agents
IL117811A0 (en) N-substituted azaheterocyclic carboxylic compounds their preparation and pharmaceutical compositions containing them
WO2000043007A1 (en) Troglitazone-containing medicinal compositions for inhibiting apoptosis
IL117812A0 (en) N-substituted heterocyclic compounds their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application